M003

R-(−)-Deprenyl hydrochloride

≥98% (HPLC), MAO-B inhibitor, powder

• Sinónimos: (R)-(−)-N,α-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride, R(−)-N-α-Dimethyl-N-2-propynyl-benzeneethanamine hydrochloride, Selegiline hydrochloride
• Fórmula empírica (notación de Hill): C₁₃H₁₇N · HCl
• Número CAS: 14611-52-0
• Peso molecular: 223.74
• UNSPSC Code: 12352200
• PubChem Substance ID: 24278577
• NACRES: NA.77
• MDL number: MFCD00069299
• Assay: ≥98% (HPLC)
• Form: powder

Propiedades

• Nombre del producto: R-(−)-Deprenyl hydrochloride, powder, ≥98% (HPLC)
• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• optical activity: [α]25/D −10.8°, c = 6.48 in H₂O(lit.)
• color: white
• mp: 141-142 °C
• solubility: H₂O: >10 mg/mL
• originator: Sanofi Aventis
• SMILES string: Cl[H].C[C@H](Cc1ccccc1)N(C)CC#C
• InChI: 1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1
• InChI key: IYETZZCWLLUHIJ-UTONKHPSSA-N
• Gene Information: human ... MAOB(4129)

Descripción

Biochem/physiol Actions

Selective MAO-B inhibitor; anti-Parkinsonian agent.

Features and Benefits

This compound is featured on the Dopamine and Norepinephrine Metabolism and Histamine Synthesis and Metabolism pages of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Información de seguridad

• Pictogramas: GHS07
• Palabra de advertencia: Warning
• Códigos de peligro: H302,H336
• Indicaciones de precaución: P301 + P312 + P330
• Hazard Classifications: Acute Tox. 4 Oral - STOT SE 3
• Órganos diana: Central nervous system
• Clase de almacenamiento: 11 - Combustible Solids
• ¿Qué está pasando?: WGK 1
• Punto de inflamación (°F): Not applicable
• Punto de inflamación (°C): Not applicable
• EPI (equipos de protección individual): Eyeshields, Gloves, type N95 (US)